Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Nothing Generic About Watson Stock
Barron's
Saturday, June 23, 2012 - 1:18pm
tags:
Watson
NPS Pharma shares rise on positive opinion for bowel drug from European committee
Proactive Investors
Saturday, June 23, 2012 - 1:15pm
tags:
NPS Pharmaceuticals, short bowel syndrome, revestive
AMAG To Get $15 Million Milestone Payment From Takeda as Iron Therapy Drug Approved for Europe
WSJ
Saturday, June 23, 2012 - 1:12pm
tags:
Takeda, Amag Pharmaceuticals, anemia, Ferumoxytol
Pharmaceutical Giant Has Statistical Chance to Go Higher
Hot Stocked
Saturday, June 23, 2012 - 1:11pm
tags:
Teva Pharmaceuticals
WuXi PharmaTech: ideal for both value investing and trading
Emerging Money
Saturday, June 23, 2012 - 1:06pm
tags:
WuXi PharmaTech
Losing the Battle and the War
Motley Fool
Saturday, June 23, 2012 - 12:13pm
tags:
JNJ, Xarelto, acute coronary syndrome
Eli Lilly And Company: Today's Featured Health Care Winner
The Steet
Saturday, June 23, 2012 - 12:09pm
tags:
Eli Lilly
Pfizer Inc: Today's Featured Drugs Winner
The Steet
Saturday, June 23, 2012 - 12:08pm
tags:
Pfizer
Wis. Supreme Court upholds damages in drug lawsuit
Yahoo/AP
Saturday, June 23, 2012 - 12:07pm
tags:
lawsuits, Pharmacia, Pfizer
Johnson & Johnson Upgraded On Synthes Approval
Motley Fool
Saturday, June 23, 2012 - 12:06pm
tags:
JNJ, Synthes
NVO Candidate to Step into Phase III
Yahoo/Zacks
Saturday, June 23, 2012 - 12:05pm
tags:
Novo Nordisk, semaglutide, diabetes, type 2 diabetes
Healthcare Biz Recap: J&J Blocked, Repligen Craters, Arena AXED
Wall Street Cheat Street
Saturday, June 23, 2012 - 12:03pm
tags:
JNJ, Repligen, Arena Pharmaceuticals
These Stocks Avoided the Market's Squeeze
Motley Fool
Saturday, June 23, 2012 - 12:02pm
tags:
Celgene, Chelsea Therapeutics, ONYX Pharmaceuticals
Momenta Pharmaceuticals Announces Decision in Teva Patent Litigation
Yahoo/GlobeNewsWire
Saturday, June 23, 2012 - 12:01pm
tags:
Momenta, Teva Pharmaceuticals, Patent Infringement, lawsuits
Cramer: What Celgene’s Europe News Means
CNBC
Saturday, June 23, 2012 - 12:00pm
tags:
Celgene, Revlimid, ONYX Pharmaceuticals, kidney cancer, liver cancer
Osiris Keeps Neutral Recommendation
Yahoo/Zacks
Saturday, June 23, 2012 - 11:55am
tags:
Osiris Therapeutics
Arena Sold Out? (video)
CNBC
Saturday, June 23, 2012 - 11:53am
tags:
Arena Pharmaceuticals, lorcaserin, obesity, weight loss
Former Drug Developer Discovers Next-Generation Biotech Stocks
Motley Fool
Saturday, June 23, 2012 - 11:52am
tags:
Amarin, Ironwood Pharmaceuticals, Medivation
Arena Declines As Column Warns Of Crash After 10-Day Run
Bloomberg
Saturday, June 23, 2012 - 11:49am
tags:
Arena Pharmaceuticals, lorcaserin, obesity, weight loss
Intermune Concludes Sale of Actimmune
Yahoo/Zacks
Saturday, June 23, 2012 - 11:48am
tags:
InterMune, Actimmune

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.